P53 and NF-κB coregulate proinflammatory gene responses in human macrophages

Cancer Research

Volumn 74, Issue 8, 2014, Pages 2182-2192

  Lowe, Julie M ^a   Menendez, Daniel ^a   Bushel, Pierre R ^b   Shatz, Maria ^a   Kirk, Erin L ^c   Troester, Melissa A ^c   Garantziotis, Stavros ^a   Fessler, Michael B ^a   Resnick, Michael A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Biostatistics Branch   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; NUTLIN 3; PROTEIN P53; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTOMICS; TUMOR ASSOCIATED LEUKOCYTE;

HUMANS; IMIDAZOLES; IMMUNITY, CELLULAR; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MACROPHAGES; MICROARRAY ANALYSIS; NF-KAPPA B; PIPERAZINES; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84899579100     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-1070     Document Type: Article

References (50)

1. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007;445:656-60.
2. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011;331:1565-70.
3. Allavena P, Mantovani A. Immunology in the clinic review series; focus on cancer: tumour-Associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin Exp Immunol 2012;167: 195-205.
4. Solinas G, Schiarea S, Liguori M, Fabbri M, Pesce S, Zammataro L, et al. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J Immunol 2010;185:642-52.
5. Grugan KD, McCabe FL, Kinder M, Greenplate AR, Harman BC, Ekert JE, et al. Tumor-Associated macrophages promote invasion while retaining Fc-dependent anti-tumor function. J Immunol 2012;189: 5457-66.
6. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat Immunol 2011;12:695-708.
7. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 2011;12:715-23.
8. Lane D, Levine A. p53 Research: the past thirty years and the next thirty years. Cold Spring Harb Perspect Biol 2010;2:a000893.
9. Munoz-Fontela C, Macip S, Martinez-Sobrido L, Brown L, Ashour J, Garcia-Sastre A, et al. Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med 2008;205:1929-38.
10. Menendez D, Shatz M, Azzam K, Garantziotis S, Fessler MB, Resnick MA. The toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet 2011;7: e1001360.
11. Shatz M, Menendez D, Resnick MA. The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells. Cancer Res 2012;72:3948-57.
12. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997;387:296-9.
13. Huang WC, Ju TK, Hung MC, Chen CC. Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell 2007;26:75-87.
14. Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-kappaB in p53- mediated programmed cell death. Nature 2000;404:892-7.
15. Schneider G, Kramer OH. NFkappaB/p53 crosstalk-A promising new therapeutic target. Biochim Biophys Acta 2011;1815:90-103.
16. Levin DG, Bassett M, Chall AN, Ghio AJ, Bromberg PA. Bronchoscopy in healthy volunteers. Am J Resp Crit Care 1999;159:A708-A.
17. Hiebl B, Fuhrmann R, Franke RP. Characterization of cryopreserved CD14+-human monocytes after differentiation towards macrophages and stimulation with VEGF-A(165). Clin Hemorheol Microcirc 2008;39: 221-8.
18. Menendez D, Nguyen TA, Freudenberg JM, Mathew VJ, Anderson CW, Jothi R, et al. Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells. Nucleic Acids Res 2013;41:7286-301.
19. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004;303:844-8.
20. DeForge LE, Remick DG. Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun 1991;174:18-24.
21. Hoffmann A, Natoli G, Ghosh G. Transcriptional regulation via the NFkappaB signaling module. Oncogene 2006;25:6706-16.
22. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 2000;14:981-93.
23. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999;285:1733-7.
24. Liu G, Park YJ, Tsuruta Y, Lorne E, Abraham E. p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury. J Immunol 2009;182:5063-71.
25. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A 1993;90: 10193-7.
26. Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 1990;10:1498-506.
27. Frank AK, Leu JI, Zhou Y, Devarajan K, Nedelko T, Klein-Szanto A, et al. The codon 72 polymorphism of p53 regulates interaction with NF- {kappa}B and transactivation of genes involved in immunity and inflammation. Mol Cell Biol 2011;31:1201-13.
28. Schneider G, Henrich A, Greiner G, Wolf V, Lovas A, Wieczorek M, et al. Cross talk between stimulated NF-kappaB and the tumor suppressor p53. Oncogene 2010;29:2795-806.
29. Huang B, Yang XD, Lamb A, Chen LF. Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. Cell Signal 2010;22:1282-90.
30. Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, et al. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002;100:1828-34.
31. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990;10: 2327-34.
32. Menendez D, Inga A, Resnick MA. Potentiating the p53 network. Discov Med 2010;10:94-100.
33. Ma S, Tang J, Feng J, Xu Y, Yu X, Deng Q, et al. Induction of p21 by p65 in p53 null cells treated with Doxorubicin. Biochim Biophys Acta 2008;1783:935-40.
34. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995;9:935-44.
35. Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, Appella E, et al. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res 2008;68:3193-203.
36. Reimand J, Kull M, Peterson H, Hansen J, Vilo J. g:Profiler-A webbased toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res 2007;35:W193-200.
37. Kobayashi Y. The role of chemokines in neutrophil biology. Front Biosci 2008;13:2400-7.
38. Stewart DA, Yang Y, Makowski L, Troester MA. Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res 2012;10:727-38.
39. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-Associated cancer. Cell 2004;118:285-96.
40. Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, et al. Control of the senescence-Associated secretory phenotype by NFkappaB promotes senescence and enhances chemosensitivity. Genes Dev 2011;25:2125-36.
41. Arpin D, Perol D, Blay JY, Falchero L, Claude L, Vuillermoz-Blas S, et al. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 2005;23:8748-56.
42. Chen Y, Hyrien O, Williams J, Okunieff P, Smudzin T, Rubin P. Interleukin (IL)-1A and IL-6: applications to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2005;62:260-6.
43. Dey A, Wong ET, Bist P, Tergaonkar V, Lane DP. Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy. Cell Cycle 2007;6:2178-85.
44. Kadekaro AL, Chen J, Yang J, Chen S, Jameson J, Swope VB, et al. Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes. Mol Cancer Res 2012;10:778-86.
45. Verma R, Rigatti MJ, Belinsky GS, Godman CA, Giardina C. DNA damage response to the Mdm2 inhibitor nutlin-3. Biochem Pharmacol 2010;79:565-74.
46. Valentine JM, Kumar S, Moumen A. A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation. BMC Cancer 2011;11:79.
47. Rigatti MJ, Verma R, Belinsky GS, Rosenberg DW, Giardina C. Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells. Mol Carcinog 2012;51:363-78.
48. Yang J, Ahmed A, Poon E, Perusinghe N, de Haven Brandon A, Box G, et al. Small-molecule activation of p53 blocks hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia. Mol Cell Biol 2009;29:2243-53.
49. Liu H, Perlman H, Pagliari LJ, Pope RM. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation. J Exp Med 2001;194:113-26.
50. WuH, Lozano G. NF-kappa Bactivation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 1994;269:20067-74.